Tectonic Therapeutic, Inc. — Director's Dealing 2018

Jun 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2018-06-20

Reporting Person: Donenberg Phillip B. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-20	Stock Option (Right to Buy)	$19.00	A	18743	Acquired	2028-06-20	Common Stock (18743)	Direct

Footnotes

F1: The shares vest in 36 equal monthly installments following the closing of the Issuer's initial public offering.